Gynecology

08:30-10:00	HRT AND CANCER	HALL B
Capsule	Is there a relationship between HRT and cancer?
Chairpersons	Santiago Palacios, Spain Sven O. Skouby, Denmark
08:30-08:50	WHO claims, “Estrogens are carcinogenic”. Is this true?
08:50-09:10	Can HRT and treatment for menopause be individualized to reduce the incidence of breast cancer? Mark Brincat, Malta
09:10-09:40	Breast cancer in special populations Herjan Coelingh Bennink, Netherlands
09:40-10:00	HRT in cancer survivors

10:00-10:20

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:20-11:50

INDUSTRY SUPPORTED SESSION

HALL B

11:50-12:10

Break

12:10-13:40	VULVAR AND VAGINA	HALL B
Capsule
Chairperson	Nick Panay, UK
12:10-12:30	Advances in anatomy and physiology of the vagina based on new treatments Santiago Palacios, Spain
12:30-12:50	Vulvar pains and co-morbidities: Data from 1183 cases Alessandra Graziottin, Italy
Capsule	Postmenopausal atrophy of the lower genital and urinary tract is distressing and require new ideas to control symptoms
12:50-13:20 12:50 13:00 13:10	Debate: Is laser effective for treatment of Stress Urinary Incontinence (SUI) Yes: Zdenko Vizintin, Slovenia No: Tim Hillard, UK Discussion
13:20-13:40	Translational medicine in reproductive ageing Sven O. Skouby, Denmark

13:40-14:30

Lunch break, poster viewing and visit the exhibition

Exhibition Area

14:30-16:30	PRESCRIBING HRT	HALL B
Capsule
Chairpersons	Mark Brincat, Malta Alessandra Graziottin, Italy
Capsule	The controversy surrounding androgen addition to HRT is ongoing
14:30-15:00 14:30 14:40 14:50	Debate: Should androgens be routinely offered to optimize quality of life in menopause? For: Alessandra Graziottin, Italy Against: Discussion
15:15-15:40	Update on practical prescribing of new hormone therapy regimens Nick Panay, UK
15:40-16:05	New strategies in the prevention of fragility fractures Santiago Palacios, Spain
16:05-16:30	Use of HRT for cardiovascular prevention Christian Ergater, Austria

16:30-16:50

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:00-10:20

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:20-11:50	WOMEN’S HEALTH AND WEALTH A PREIS SCHOOL ACADEMY SESSION	HALL B
Capsule
Chairperson	Gian Carlo Di Renzo, Italy
10:20-10:25	Welcome Gian Carlo Di Renzo, Italy
10:25-10:35	The Welfare of Women (WoW) global health program endorsed by FIGO Gian Carlo Di Renzo, Italy
10:35-10:50	Will body-identical MHT become the first choice for menopausal hormone therapy?
10:50-11:05	Testosterone or not Testosterone in menopause: That’s the question! Nick Panay, UK
11:05-11:20	Which progestogen to optimize breast and endometrial safety in MHT? Ewald Boschitsch, Austria
11:20-11:50	Discussion

11:50-12:00

Break

12:00-13:30	IN SEARCH OF NEW PERSPECTIVES: POI MAINLY DRIVEN BY GENETICS	HALL B
Capsule
Chairperson	Bart Fauser, Netherlands Nick Panay, UK
12:00-12:25	Is the ovary the mirror of longevity? Micheline Misrahi, France
12:25-12:45	Genetic architecture of reproductive ageing Felix Day, UK
12:45-13:05	FMR1 and the genetic control of follliculogenesis Julia Rehnitz, Germany
13:05-13:30	Endo-ERN and POI Luca Persani, Italy

13:30-14:20

Lunch break, poster viewing and visit the exhibition

Exhibition Area

15:50-16:00

Break

GYNECOLOGY